What Is an LVAD Cannula?
An LVAD cannula is the tubing system that connects a left ventricular assist device to the heart and the aorta. It serves as the conduit through which blood is drawn from the left ventricle and returned to the systemic circulation. In continuous-flow devices, the cannula must accommodate non-pulsatile hemodynamics while minimizing hemolysis and thrombosis. The design and material of the cannula directly affect pump performance, patient mobility, and long-term outcomes.
More from this site
Keep reading the latest coverage
Types of LVAD Cannulae
Manufacturers produce several cannula configurations, each suited to different surgical approaches and patient anatomies. The two broad categories are percutaneous (transcutaneous) cannulae used with pulsatile devices and the integrated cannulae built into modern continuous-flow pumps.
| Cannula Type | Typical Use | Key Feature |
|---|---|---|
| Periventricular (polyurethane) cannula | Pulsatile LVADs (e.g., HeartMate XVE) | External drive line; requires driveline care |
| Integrated inflow/outflow | Continuous-flow devices (e.g., HeartMate 3) | No external percutaneous component |
| Axial-flow cannula | HeartAssist5, Jarvik 2000 | Smaller profile; apical insertion |
| Centrifugal cannula | HVAD, HeartMate 3 | Reduced shear stress; lower hemolysis risk |
Inflow Cannula Placement
The inflow cannula is typically inserted into the left ventricular apex through a left thoracotomy or median sternotomy. Surgeons use a circular stylet to create a precise opening in the myocardium, then suture the cannula flange directly to the epicardium. The orientation of the inflow tip matters: it must avoid suction events against the ventricular wall, which can cause arrhythmias or pump stoppage. Recent designs incorporate a flexible apical plug that reduces tissue ingrowth and eases eventual device exchange.
Outflow Cannula Routing
The outflow cannula connects the pump to the ascending aorta. It is usually positioned in a non-planar curve to prevent kinking and to reduce the risk of aortoenteric fistula formation. In the HeartMate 3, the outflow graft is sewn to the aorta with a reinforced polypropylene suture line. Proper positioning on the anterior or lateral aortic wall depends on the patient's anatomy, the presence of atherosclerotic disease, and the need to avoid compression of adjacent structures.
Percutaneous Driveline and Cannula Interface
For devices that require an external drive line, the percutaneous cannula exit site is a critical focus of care. The driveline traverses the skin and must be secured with a Dacron cuff that promotes tissue ingrowth to create a biological barrier against infection. Infection at the cannula exit remains one of the most common and serious complications of mechanical circulatory support. Management includes daily cleaning, antimicrobial dressings, and patient education on keeping the site dry and intact.
Complications Associated with LVAD Cannulae
Cannula-related complications span mechanical, thrombotic, and infectious domains.
- Thrombosis and pump thrombosis: Stasis within the cannula or malposition can lead to clot formation, increased power consumption, and hemolysis.
- Hemolysis: High shear stress at the inflow cannula tip or within the pump housing can rupture red blood cells, elevating plasma free hemoglobin.
- Infection: Percutaneous driveline infections can progress to pump pocket infections or endocarditis.
- Cannula malposition: Migration or kinking can reduce cardiac output and require revision surgery.
- Aortic root pathology: Outflow cannula-related aortic valve incompetence or pseudoaneurysm formation requires vigilant imaging surveillance.
Monitoring and Long-Term Management
Routine surveillance includes echocardiography to assess cannula position and ventricular remodeling, pump parameter trending to detect early thrombosis, and laboratory monitoring of lactate dehydrogenase, plasma free hemoglobin, and INR. Patients with percutaneous cannulae require lifelong driveline care training. When a device is explanted or exchanged, the cannula is carefully dissected from the myocardium and aorta, and the insertion sites are oversewn or patched with bovine pericardium.
Future Directions
Ongoing developments aim to eliminate the percutaneous driveline entirely through fully implantable, transcutaneous energy transfer systems. These designs would remove the primary infection route associated with external cannulae. Other innovations include cannula surfaces coated with heparin or antimicrobial agents to reduce thrombogenicity and infection risk, as well as flexible, low-profile inflow cannulae designed to preserve native ventricular function in patients who are candidates for recovery or bridge-to-transplant.